Table 1.
Clinical features of the study population
| Characteristics | |
|---|---|
| Age (years) | |
| Median (range) | 61 (35–91) |
| Sex | |
| Male | 17 (55) |
| Female | 14 (45) |
| Marital status | |
| Never married | 2 (6) |
| Married | 20 (64) |
| Divorced | 4 (13) |
| Widowed | 3 (10) |
| Cohabiting | 2 (6) |
| Education | |
| No formal schooling | 1 (3) |
| Primary school | 2 (6) |
| Secondary school | 13 (42) |
| High school | 11 (35) |
| Postgraduate degree | 4 (13) |
| Work status (over the past 12 months before inclusion) | |
| Government employee | 2 (6) |
| Nongovernment employee | 8 (26) |
| Homemaker | 1 (3) |
| Retired | 16 (52) |
| Unemployed (able to work) | 1 (3) |
| Unemployed (unable to work) | 3 (10) |
| WHO performance status | |
| 0/1 | 9 (29)/11 (35) |
| 2/3 | 2 (6)/2 (6) |
| Not available | 7 (24) |
| Primary tumor site | |
| Colorectal | 12 (39) |
| Pancreas | 9 (29) |
| Breast | 5 (16) |
| Others | 5 (16) |
| Recurrent disease | |
| Yes/no | 11 (35)/20 (65) |
| Number of metastatic sites | |
| 0 | 7 (23) |
| 1 | 24 (77) |
| Comorbidities | |
| None | 24 (78) |
| Diabetes | 5 (16) |
| Hepatitis B | 1 (3) |
| Chronic heart failure | 1 (3) |
| Prior cancer surgery | |
| None | 11 (35) |
| Primary tumor only | 12 (39) |
| Primary tumor and metastases | 8 (26) |
| Prior chemotherapy | |
| None | 3 (10) |
| Adjuvant and metastatic | 16 (52) |
| Adjuvant only | 11 (36) |
| Metastatic only | 1 (3) |
| Number of prior chemotherapy protocols for metastatic disease | |
| None | 13 (42) |
| 1 | 4 (13) |
| ≥2 | 12 (39) |
| Unknown | 2 (6) |
| Noncancer treatments | |
| None | 25 (81) |
| Insulin | 3 (10) |
| Pain killer | 2 (6) |
| Antiretroviral | 1 (3) |
| Thyroid hormone replacement | 1 (3) |
| Beta blocker | 1 (3) |
Data presented as number (%) of patients unless otherwise indicated.